Abstract
Background
Community-acquired pneumonia is a common and potentially serious infection that afflicts children throughout the world; it is fundamentally different in children and in adults. The annual incidence of pneumonia in children younger than 5 years of age is 34 to 40 cases per 1000 in Europe and North America, higher than at any other time of life, except perhaps in adults older than 75 or 80 years of age. 1 In the developing worldespecially, pneumonia is not only more common than it is in Europe and North America 2 it is also more severe and is the largest killer of children 3 Definitions of pneumonia vary widely. Some require only the presence of infiltrates on a chest radiograph, whereas others require only certain respiratory symptoms or signs.
Definitions are a particular problem in the case of small infants, since pneumonia and bronchiolitis are both common in this age group, and the features of these two diseases often overlap. Many studies, particularly those in the developing world, use the term "acute lower respiratory tract illness" and make no attempt to differentiate pneumonia from bronchiolitis. 2 For the purposes of this review, and particularly with respect to recommendations for treatment, pneumonia will be defined as the presence of fever, acute respiratory symptoms, or both, plus evidence of parenchymal infiltrates on chest radiography.
Etiology
A very large number of microorganisms can cause childhood pneumonia, and determining the cause of an individual case may be difficult. The lung itself is rarely sampled directly, and sputum representing lowerairway secretions can rarely be obtained from children. In addition, as is the case in adults, culture of secretions from the upper respiratory tract is not useful, since the normal flora includes the bacteria commonly responsible for pneumonia.
Multiple investigations of pediatric pneumonia during the 1960s and 1970s in North America and Europe emphasized the importance of infections with respiratory viruses (respiratory syncytial virus, influenzavirus, parainfluenza viruses, and adenovirus) in preschool children, Mycoplasma pneumoniae in schoolage children, and Chlamydia trachomatis in infants between two weeks and four months of age. More recently, C. pneumoniae has been found in school-age children with pneumonia, [5] [6] [7] [8] Similarly, the roles of cytomegalovirus, Ureaplasma urealyticum, Pneumocystis carinii, and more recently, rhinoviruses 4 as causes of community-acquired pneumonia in otherwise healthy infants and children remain controversial.
The role of bacteria as a cause of severe pneumonia is best documented in lung-puncture studies, which have been conducted largely in the developing world. [9] [10] These have confirmed the importance of Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilusinfluenzae, including non-typable strains, as causes of severe pneumonia.
There have been efforts over the past decade to define this role more clearly, largely through the measurement of bacterial antigens, nucleic acid (by means of the polymerasechain-reaction assay), antibodies, or immune complexes in blood or urine. 4, [11] [12] [13] [14] [15] [16] The value of these tests is, however, questionable. Antigen tests lack specificity, 38 and evidence of the sensitivity and specificity of bacterial antibody tests in children is either absent (in the case of non-typable H. influenzae and Moraxella catarrhalis) or severely limited (S. pneumoniae). 10 the apparent 35 percent reduction in the incidence of disease associated with the use of the recently licensed pneumococcal conjugate vaccine may provide the clearest estimate of the role of S. pneumoniae in causing childhood pneumonia in Europe and the United States. [17] [18] Diagnosis Establishing a microbiologic diagnosis, despite its limitations, may be important in children with severe or complicated pneumonia or in those with unusual but treatable causes. As a practical matter, however, the cause of pneumonia can usually be surmised on the basis of clinical and epidemiologic data, findings on chest radiography, and a few laboratory tests such as a complete blood count, erythrocyte sedimentation rate, and levels of C-reactive protein. Although it is difficult to determine the accuracy of such nonmicrobiologic diagnostic approaches because of the lack of an etiologic gold standard, there have been many attempts to correlate them with microbiologic causes.
Radiographic findings have less discriminatory value than does measurement of C-reactive protein, erythrocyte sedimentation rate, or the white-cell count and the differential count. alveolar (equivalent to a "lobar") infiltrate is an insensitive but reasonably specific indication of bacterial infection. typical bronchiolitis with scattered infiltrates to dense lobar pneumonia with a large pleural effusion the level of diagnostic certainty provided by radiologic findings is quite high. [20] [21] [22] Non-microbiologic laboratory tests have also been widely used in an attempt to differentiate bacterial from nonbacterial pneumonia. However, they are not much better than chest radiographs. Several analyses show that the C-reactive protein level and the absolute neutrophil count are the most helpful. [23] [24] [25] [26] Treatment Perhaps because of the many controversies that surround the etiologic process of community-acquired pneumonia in children, there have been few attempts to devise treatment guidelines in Europe or North America. In contrast, official recommendations regarding the treatment of pneumonia in adults have been published in Britain, Canada, and the United States. [27] [28] [29] An ad hoc group of Canadian experts has published guidelines, 30 and numerous recommendations address subgroups of patients with pneumonia, which are usually classified according to the cause. [31] [32] [33] These guidelines, however, are designed for areas where pneumonia is a major killer, bacterial pneumonia is probably more common, access to drugs is limited, and the available diagnostic tools are few. 34 Pneumonia during the first three weeks after birth is uncommon, but when it does occur it is often related to perinatally associated infections. Between three weeks and three months of age, two of the most important causes of pneumonia are macrolide-sensitive organisms: C. trachomatis is also one of the most common, and Bordetella pertussis is an infrequent cause of pneumonia. These pneumonias usually have an interstitial pattern of infiltrates, with cough as a prominent feature. In children who are older than five years of age, two other macrolide-sensitive organisms, M. pneumoniae and C. pneumoniae, cause pneumonia that, on chest radiograph, is often not distinguishable from bacterial pneumonia but that is characterized by cough, a low-grade fever, and sometimes wheezing. M. pneumoniae is the most common identified cause of pneumonia among children who are 5 to 15 years of age.
A child with pneumonia who is wheezing is likely to have a viral, M. pneumoniae, or C. pneumoniae infection. 35 Respiratory syncytial virus infection and influenza are uncommon outside their winter-spring epidemics. M. pneumoniaeepidemics are less predictable cases do occur in community-wide clusters during the winter.
Chest radiographs that show consolidative lobar infiltrates, particularly if either a large pleural effusion or any parenchymal necrosis is present, are indicative of a bacterial cause. When the whitecell count, differential count, and C-reactive protein level are very abnormal, they also have predictive value with respect to bacterial pneumonia and can corroborate a diagnosis 36 In infants who are 3 weeks to 3 months of age and in those who are 5 to 15 years of age, a macrolide antibiotic is the most reasonable first, second-or thirdgeneration cephalosporin should be used for children with sepsis, except forinfants, who should receive bothampicillin and gentamicin, as well as a thirdgeneration cephalosporin in severe cases. In areas where methicillin-resistant strains of S. aureus have appeared,vancomycin should then be added to the regimen. If the condition of school-age children does not improve with the use of cephalosporin or if the findings on the chest radiograph or the clinical findings are ambiguous, a macrolide should be added [37] [38] [39] ,
The emergence of strains of S. pneumoniae that are not susceptible to penicillin a second-generation cephalosporin (cefuroxime) or a third-generation cephalosporin (cefotaxime or ceftriaxone) is somewhat more effective.high dose of amoxicillin (80 to 100 mg per kilogram of body weight per day) is the preferred treatment for pneumonia in outpatients. Vancomycin is rarely needed to treat pneumococcal pneumonia, even severe cases. [40] [41] Use of the recently licensed pneumococcal conjugate vaccine appears likely to prevent the majority of cases of pneumococcal pneumonia,vaccinated persons that pneumococcal serotypes not represented in the vaccine are replacing the serotypes covered by the vaccine and are causing otitis media. 42 The World Health Organization's approach to the treatment of pneumonia, despite its success, may well aggravate the problem of antibiotic resistance in communities that have the highest rates of death from pneumonia. 43 
Conclusions
Pneumonia in children has been relatively refractory to efforts and to reduce its incidence and severity. The use of treatment algorithms in the developing world has led to lower mortality rates. There is still room for improvements in the diagnosis of pneumonia and in the elucidation of its cause in individual cases. Finally, regional consensus guidelines for management and antimicrobial treatment should be developed for appropriate management of community acquired pneumonia.
